The Company's innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical ...

With an aging baby boomer population who have substantial disposable income, it’s no wonder that companies that deal in cosmetic procedures have performed well. It’s no secret that this generation ...

Syneron Medical (NASDAQ:ELOS) says it's received FDA clearance for elos Plus, an Aesthetic Work Station that features the company's proprietary elos technology. The FDA clearance follows on its recent ...

Revenue: Second quarter 2015 revenue was $73.5 million, up 14%, compared to $64.6 million in the second quarter 2014. Second quarter 2015 constant currency revenue growth was 19%, when excluding the ...

Syneron Medical ELOS, www.syneron.com, the leading global aesthetic device company, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to ...

Feb 27 (Reuters) - Syneron Medical Ltd. and Procter & Gamble Co. said they will jointly develop and market Syneron's elos-based home-use devices and compositions for skin treatments. Shares of ...